Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Oct 22 2026 UPDATED 9:49 AM

Full Issue

Testosterone For Menopause Might Elevate Heart Hazards, Study Finds

"Our findings suggest that testosterone use is associated with a higher risk of cardiovascular events in postmenopausal women," one of the researchers told MedPage Today, emphasizing that the observational findings do not indicate a causal link and more studies are needed.

MedPage Today: Testosterone For Menopause May Carry Heart Risks

Testosterone therapy for menopause was linked to heightened risk of incident cardiovascular disease, a large retrospective cohort study suggested. (Robertson, 10/21)

CIDRAP: US Cervical Cancer Screening Rates Have Risen, But Disparities Remain, New Data Show

Since the 1970s, cervical cancer deaths in the United States have plummeted by more than half, thanks in part to screening, according to the American Cancer Society. Still, about 13,000 women receive new cervical cancer diagnoses annually—and about 4,000 of them die. Understanding cervical cancer screening (CCS) uptake trends can help doctors reach more patients and reduce the number of deaths. From 2019 to 2024, rates of CCS increased overall, but there were differences among the groups screened, finds a study published late last week in JAMA Network Open. (Holohan, 10/21)

MPR News: As Obstetric Care Dwindles In Rural Minnesota, New Fellowship Aims To Fill Gaps 

Nearly 30 Minnesota hospitals have stopped providing obstetric services over the past 15 years, leaving fewer options for families who need maternity care close to home, according to University of Minnesota research. (Gordon and Finn, 10/21)

NBC News: EXCLUSIVE: Nurse, 33, Diagnoses Own Breast Cancer After Doctor, Scans Missed The Signs

In October of 2023, Marci Bothwell had just turned 33 and completed her certification to become an oncology nurse. The mom of three was very knowledgable about the symptoms of many cancers, and how to monitor for them. But she wasn’t looking for unusual changes in her breasts when she found one. (Kee, 10/21)

In other public health news —

CIDRAP: Kids More Likely To Be Vaccinated Against HPV If Doctors Offer Shots At Earlier Ages, Study Finds

When it comes to protecting kids from the human papillomavirus (HPV), earlier vaccination is better, new research shows. Children are more likely to be fully vaccinated against HPV—a ubiquitous virus that causes six types of cancer— if doctors offer the immunization when kids are 9 or 10 years old, compared with beginning the series of injections at ages 11 or 12, the age when most clinicians now offer the shots. (Szabo, 10/21)

CBS News: We Bought And Tested What Was Sold As An Experimental Weight Loss Drug. The Lab Results Were 'Pretty Terrifying.'

A drug that's not FDA approved and still in clinical trials is being advertised all over the internet. Buying it turned out to be alarmingly easy. First, CBS News national correspondent Adam Yamaguchi placed an online order through the website for Reset Wellness, a clinic started by a nurse practitioner, for 20 milligrams of retatrutide. The weight-loss medication, known as Reta, is an experimental peptide drug that Eli Lilly is studying as a next-generation obesity treatment. At checkout, he was promised a health evaluation, but the product arrived a week later without ever having to speak to a health professional. (Yamaguchi and Geller, 10/21)

Newsweek: Children’s Toothpaste Among 4M Tubes Recalled Over Potential Health Risk

More than 4.3 million tubes of toothpaste, including children's products featuring popular characters such as Barbie, Hot Wheels, Crayola and My Little Pony, have been recalled nationwide, according to the U.S. Food and Drug Administration (FDA). The voluntary recall affects 17 toothpaste varieties sold under the Brush Buddies, evo and ARU brands. The FDA lists “current good manufacturing practice deviations” as the reason, but does not specify the exact manufacturing issues. The agency classified the recall as Class II on October 19. (Backus, 10/22)

Pope Leo's cancer prognosis —

AP: Pope Leo Needs No Further Treatment For Lung Cancer After Tests, Vatican Says

Pope Leo XIV will need no further treatment for lung cancer after tests confirmed the disease was localized, the Vatican said Wednesday. Leo, 71, had part of one lung removed last week in the first major health event of his 17-month pontificate. The surgery confirmed he had adenocarcinoma, the most common type of lung cancer. Leo was discharged from Rome’s Gemelli Polyclinic on Saturday, four days after surgery, and said he would gradually resume his activities. (10/22)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, October 22
  • Wednesday, October 21
  • Tuesday, October 20
  • Monday, October 19
  • Friday, October 16
  • Thursday, October 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF